Daraprim

Page 2 of 2

J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Health

Valeant under federal investigation for how it prices drugs

By
October 15, 2015
The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
Health

The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach

By
September 29, 2015
MSMB Capital Management CIO Martin Shkreli
Health

Record label cuts ties with besieged pharma CEO Martin Shkreli

By
September 25, 2015
GOP Candidate For President Donald Trump Campaigns In Columbia, South Carolina
Leadership

Donald Trump on drug price-raising CEO: ‘Spoiled brat’

By
September 24, 2015
MSMB Capital Management CIO Martin Shkreli
Health

Turing backs down on Daraprim drug pricing

By
September 23, 2015
157934085
Health

Doctors respond to Turing drug price hike: ‘It’s scare mongering’

By
September 22, 2015
MSMB Capital Management CIO Martin Shkreli
Health

Here’s why Turing Pharmaceuticals says 5,000% price bump is necessary

By
September 22, 2015
Picture taken on January 15, 2012 in Lil
Health

This 62-year-old drug just got 5,000% more expensive

By
September 21, 2015

Most Popular